Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | SATL Satellogic Inc. | 13G/A | 0.04% | Mar 31, 2026 | 6mo |
| Portolan Capital Management, LLC | REAX Real REMAX Group Inc. | 13G/A | 6.8% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | DCOM Dime Commercial Bancshares, Inc. | 13G/A | 4.5% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | JCAP Jefferson Capital, Inc. | 13G | 5.9% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | FVRR Fiverr International Ltd. | 13G/A | 8.5% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | SGMOQ Sangamo Therapeutics, Inc | 13G | 9.75% | Mar 31, 2026 | 6mo |
| CANADA PENSION PLAN INVESTMENT BOARD | SM SM Energy Co | 13G/A | 6.1% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | VMRK Vivmark Residential | 13G/A | 4.8% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | ERAS Erasca, Inc. | 13G/A | 6.8% | Mar 31, 2026 | 6mo |
| Cinctive Capital Management LP | LZM Lifezone Metals Ltd | 13G/A | 11.8% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | DAO Youdao, Inc. | 13G/A | 21.5% | Mar 31, 2026 | 6mo |
| Fort Baker Capital Management LP | EGHA EGH Acquisition Corp. | 13G | 6% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | SYNA SYNAPTICS Inc | 13G/A | 19.5% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | SOC Sable Offshore Corp. | 13G/A | 1.83% | Mar 31, 2026 | 6mo |
| HARRIS ASSOCIATES L P | CNH CNH Industrial N.V. | 13G/A | 4.7% | Mar 31, 2026 | 6mo |
| Almitas Capital LLC | ANTX AN2 Therapeutics, Inc. | 13G/A | 4.1% | Mar 31, 2026 | 6mo |
| RA CAPITAL MANAGEMENT, L.P. | PCVX Vaxcyte, Inc. | 13G/A | 8.9% | Mar 31, 2026 | 6mo |
| Chun Yen Lim | GIBO GIBO HOLDINGS Ltd | 13G/A | 3.6% | Mar 31, 2026 | 6mo |
| Cormorant Asset Management, LP | MLTX MoonLake Immunotherapeutics | 13G/A | 6.25% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | BDX Becton Dickinson & Co | 13G/A | 3.4% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | MBWM Mercantile Bank Corp | 13G | 6.9% | Mar 31, 2026 | 6mo |
| Polar Asset Management Partners Inc. | QADR QDRO Acquisition Corp. | 13G | 7.5% | Mar 31, 2026 | 6mo |
| EcoR1 Capital, LLC | IBIO iBio, Inc. | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| Brian Venturo | CRWV CoreWeave, Inc. | 13G/A | 6.2% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | FAC Factorial Energy Inc. | 13G | 5.4% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | RKDA Arcadia Biosciences, Inc. | 13G | 7.75% | Mar 31, 2026 | 6mo |
| Longitude Capital Partners II, LLC | RPID Rapid Micro Biosystems, Inc. | 13G/A | 8.6% | Mar 31, 2026 | 6mo |
| Jacob Suen | AIRG Airgain Inc | 13G/A | 6.6% | Mar 31, 2026 | 6mo |
| Iroquois Capital Management, LLC | FABC Fabric.AI, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| ADAR1 Capital Management, LLC | LONA LeonaBio, Inc. | 13G | 7.7% | Mar 31, 2026 | 6mo |
| Portolan Capital Management, LLC | FORR Forrester Research, Inc. | 13G/A | 7.94% | Mar 31, 2026 | 6mo |
| COOPER CREEK PARTNERS MANAGEMENT LLC | WW Ww International, Inc. | 13G/A | 9.8% | Mar 31, 2026 | 6mo |
| K2 HealthVentures Equity Trust LLC | NMRA Neumora Therapeutics, Inc. | 13G/A | 3.1% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | NWFL Norwood Financial Corp | 13G/A | 6.9% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | TALK Talkspace, Inc. | 13G | 5.31% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | ANRO Alto Neuroscience, Inc. | 13G | 7.9% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | VVOS Vivos Therapeutics, Inc. | 13G | 8.27% | Mar 31, 2026 | 6mo |
| Polar Asset Management Partners Inc. | KDK Kodiak AI, Inc. | 13G/A | 1.3% | Mar 31, 2026 | 6mo |
| LMR Partners LLP | SVIA Silvia, Inc. | 13G | 5.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | PECO Phillips Edison & Company, Inc. | 13G/A | 4.1% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | FBIO Fortress Biotech, Inc. | 13G/A | 7.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | EFSC Enterprise Financial Services Corp | 13G/A | 8.8% | Mar 31, 2026 | 6mo |
| Pencross Energy, LLC | FRMI Fermi Inc. | 13G/A | 4.5% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | IMNM Immunome Inc. | 13G/A | 14.5% | Mar 31, 2026 | 6mo |
| Manulife Investment Management (US) LLC | CZWI Citizens Community Bancorp Inc. | 13G/A | 5.01% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | ORIC Oric Pharmaceuticals, Inc. | 13G | 5.4% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | SRZN Surrozen, Inc. | 13G/A | 2.14% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | ALHC Alignment Healthcare, Inc. | 13G/A | 8.4% | Mar 31, 2026 | 6mo |
| BAMCO INC /NY/ | MTN Vail Resorts Inc | 13G/A | 14.15% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | HCMA Hcm III Acquisition Corp. | 13G | 8.2% | Mar 31, 2026 | 6mo |